Physician profile
Adam Schell
NPI 1003202086
$3,481.85
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,252 · 2021: $1,362 · 2022: $39.81 · 2023: $48.18 · 2024: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.12 |
| Travel and Lodging | $348.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,092.58 | 2020-2023 | Maxcess, Simplify Cervical Artificial Disc |
| Stryker Corporation | $648.83 | 2020-2021 | |
| Alphatec Spine, INC | $496.62 | 2021-2024 | Other - Miscellaneous |
| Medtronic, INC. | $487.17 | 2021 | |
| Globus Medical, INC. | $230.24 | 2020-2024 | Modulus, Excelsius3d Imaging System |
| Medtronic USA, INC. | $155.46 | 2020 | |
| Spineology INC. | $118.44 | 2024 | Optimesh Expandable Interbody Fusion System |
| Depuy Synthes Sales INC. | $97.77 | 2021 | |
| Cerapedics INC. | $76.94 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Ethicon US, LLC | $39.81 | 2022 | |
| Si-Bone, INC. | $19.61 | 2024 | |
| Intrinsic Therapeutics | $18.38 | 2023 | Barricaid Acd (Annular Closure Device) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Schell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.